Sign In   |   Register

 

Breaking News:

Breaking News

Trickle Research Earnings Update 11-13-18
12-24 Month Target Price $8.75

Click Here for Report

11-15-18
Canbiola, Inc. (CANB)

Canbiola, Inc. Uplists to OTCQB Venture Market.

Read Complete Press Release

Greenridge Global Equity Research
Issues Updates 11-2-18
Guangdong Land Holdings, Ltd.
Click Here>>

10-29 Mining Magazine

Could technology open doors to a cleaner-burning future for
coal? Clean Coal Technologies and the University of Wyoming are
collaborating on a cleaner, more efficient way for the US and the
world to produce and consume coal
Click Here for complete Article


Trickle Research issues update of
AzurRx Biopharma, Inc.  10-16-18
12-24 Month Price Target $10.25

Click Here for Update Report

10-11-18 Summit Wireless Technologies, Inc. (WISA)
Announces
Certification of Axiim Link
WiSA USB Transmitter
Read Complete Release

10-10-18 Ascendiant Capital markets, LLC
Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
  Buy Rating and Price Target $7.00

Click Here for Research Report

09-28-18 Trickle Research Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
12-24 Month Price Target $9.25

Click Here for Research Report

10-3-18, Endurance Exploration Group, Inc. (“EXPL”)

operating through its previously announced joint venture, Swordfish
Partners (the “Joint Venture”), is pleased to announce that
it has acquired title to over 600 items and artifacts
salvaged from the Steamship Pulaski.

 

10-1-18, Endurance Exploration Group, Inc. (“EXPL”) through a newly formed entity (or, “Affiliate”), has entered into a joint-venture with Global Marine Archaeological Research, LLC.  (“GMAR”)

Click Here

9-24-18 Trickle Research Issues Research Note
AzurRx Biopharma, Inc.
12-24 Month Price Target $10.25

Click Here for Research Note

8-23-18 Trickle Research Issues Earnings Update
PetroShare Corp 
12-24 Month Price Target $3.20

Click Here for Research Note

8-15-18 Trickle Research Issues Research Note
Command Center, Inc.  
12-24 Month Price Target $9.60

Click Here for Research Note

8-16-18 Trickle Research Issues Research Note
Social Reality, Inc.  
12-24 Month Price Target $8.50

Click Here for Research Note

Consilium Global Research Issues
Quarterly Update 8-7-18
Zynex, Inc. 
Price Target $7.00
    Click Here>>

8-1-18 Trickle Research Issues Research Note
Social Reality, Inc. 
12-24 Month Price Target $7.50

Click Here for Research Note

05-31-18 Trickle Research Initiates Research of
Petroshare Corp 
12-24 Month Price Target $3.20

Click Here for Research Report





 

  Black Swan Research
Research Coverage 7-18
SMM is now hosting Equity Research and updates from top tier research providers:           
   Catalyst Research  
 Trickle Research
Click here to Subscribe to Trickle Research 
 Falcon Strategic Research
 Consilium Global Research
 ValuEngine
 Click Here to Subscribe to Black Swan Research
              

Black Swan Newsletter

SUBSCRIBE TO THE NEWSLETTER BELOW






 

October 2018

Click here to view

Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

 

10-17-18

AxurRx BioPharma started at outperform with $6 stock price target at Oppenheimer

10-16-18 Trickle Research Initiates Research of 
AzurRx Biopharma, Inc. (AZRX)  
12-24 Month Price Target $10.25

AzurRX made an announcement this morning regarding FDA Acceptance of IND application for Phase 2 Clinical Trial of MS1819-SD in Cystic Fibrosis patients. That announcement is included below. This announcement is (another) one of the major milestones we referenced in the initial coverage as a potential catalyst to much higher valuations of the company. As with their recent announcement regarding  positive results from their Phase IIa Exocrine Pancreatic Insufficiency trial in Chronic Pancreatitis, this is in our view, very positive news. Moreover, these two releases

in conjunction with one another may provide some additional insights.

Read Complete Research Update
 

10-10-18 Ascendiant Capital markets, LLC
Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
Buy Rating and Price Target $7.00
Click Here for Research Report

 

10-9-18 Social Reality, Inc. (SRAX)
SRAX Launches BIGtoken, the Platform for Consumers to Own, Verify and Sell Their Data

Claim your data by downloading the BIGtoken mobile app, available in the Apple App Store and Google Play; up to 10,000 initial Beta testers will take part in breaking down the barriers dividing consumers from the data they produce.

During the Beta phase, the top three most active users will be rewarded with Bitcoin for their participation. To join the Beta phase, consumers, first, sign up at: http://bigtoken.com/beta. Shortly thereafter, consumers will receive an "invite code" to activate the BIGtoken app, which is, now, available for download in the Apple App Store or Google Play:

Read Complete Release

 

 

InvestorsHub News Wire:

 

 

 

Weekly Update: November 6th, 2018

Latest Happenings

Well the election is over and it seems at least a segment of the investing public is happy

Yahoo News 11-7-18

Stocks soared as the results of the US midterm elections panned out as anticipated, with Democrats winning back control of the House of Representatives and Republicans retaining the Senate.

The S&P 500 (^GSPC) rose 1.26%, or 34.84 points as of 11:34 a.m. ET. The Dow (^DJI) climbed 1.08%, or 276.85 points. The Nasdaq (^IXIC) rose 1.77%, or 130.51 points.

“In a dispassionate way the equity markets probably got the outcome they wanted. The concern that an emboldened Republican Party retaining both houses might have embraced another round of tax cuts, thereby increasing the deficit, has receded,” Jefferies analyst Sean Darby wrote in a note. “Meanwhile, the worry was that if the Democrats had won back both houses, the tax cuts and regulatory changes might have been rolled back or rescinded.”

See complete report and video

 

11-02-18 Greenbridge Global Research updates 
Guangdong Land Holdings, Limited. (HK 124)  
 Price Target $4.75

Portfolio Projects Continue Developing On Schedule

Q3:18 Results Moved By Impact of Acquisitions.  GDL reported third quarter Revenue of HK$ 20.7 million from sales at the Baohuaxuan Project.  Other notable items were the recognition of HK$ 297 million as Gain on Bargain Purchase from the July 2018 acquisitions, which was higher than the figure we had estimated.  GDL also recorded a HK$ 111 million income tax expense related to income previously received as demolition compensation.  Net Profit for the third quarter was roughly HK$ 130.4 million.

Project Portfolio Updates.  The Buxin Project continues to move on track, with the four NW Land buildings constructed up to between 25 and 35 floors.  Pre-sale activities are still expected before year-end, as is the start of construction of the Southern and Northern Land buildings.  Construction has been completed on the Zhuguanglu Project and sales are expected to start before the end of 2018.  Sales have continued at the Baohuaxuan Project, which ended September with 79.2% of the GFA sold.

Model Update.  Other than the items noted above in the third quarter results, the only change to our model was pushing out Revenue from Zhuguanglu from H2:18 to H1:19.

Maintaining Rating & Target.  GDL’s growing portfolio continues to see projects developing on schedule and units selling as originally expected.  Having positive operational momentum we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  Our target price is based on our DCF model that covers GDL’s project portfolio.

Read Complete Report


 

 

 

Community Search
Sign In